NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market on Monday that its fiscal third quarter revenues were flat but edged out the consensus Wall Street estimate. 

For the three months ended July 31, the firm posted $1.01 billion in total revenues, the same as the year-ago quarter, but just above the analysts' average estimate of $1 billion. On a core basis, revenues grew 9 percent.  

Orders in Q3 2015 were down about 6 percent year over year to $953 million from $1.02 billion. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.